Effectiveness of Fentanyl Transdermal Patch (Fentanyl-TTS, Durogegic(R)) for Radiotherapy Induced Pain and Cancer Pain: Multi-center Trial.
- Author:
Seong Soo SHIN
1
;
Seung Jae HUH
;
Eun Kyung CHOI
;
Jong Hoon KIM
;
Seung Do AHN
;
Sang Wook LEE
;
Yeun Sil KIM
;
Kyu Chan LEE
;
Chang Geol LEE
;
John JK LOH
;
Mison CHUN
;
Young Teak OH
;
Ok Bae KIM
;
Jin Hee KIM
;
Chul Yong KIM
;
Dae Sik YANG
;
Woo Yoon PARK
;
Bo Kyoung KIM
;
Heung Lae CHO
;
Ki Jung AHN
;
Jong Young LEE
;
Seon Min YUN
;
Yong Chan AHN
;
Do Hoon LIM
;
Won PARK
;
Ki Moon KANG
;
Hong Gyun WU
;
Hyun Soo SHIN
;
Seong Soon JANG
;
Eun Seog KIM
;
Byung Sik NA
;
Woong Ki JUNG
;
Sung Ja AHN
;
Taek Keun NAM
;
Yong Ho KIM
;
MI Hee SONG
;
Sang Mo YUN
;
Chul Seung KAY
;
Ji Won YEI
;
Suk Won PARK
;
Seon Woo KIM
Author Information
- Publication Type:Multicenter Study ; Original Article
- Keywords: Cancer pain; Radiotherapy induced pain; Fentanyl Transdermal Patch
- MeSH: Academies and Institutes; Acute Pain; Analgesics; Female; Fentanyl*; Humans; Male; Nausea; Prospective Studies; Quality of Life; Radiotherapy*; Sleep Initiation and Maintenance Disorders; Transdermal Patch*
- From:The Journal of the Korean Society for Therapeutic Radiology and Oncology 2006;24(4):263-271
- CountryRepublic of Korea
- Language:Korean
- Abstract: PURPOSE: To evaluate the effectiveness and safety of fentanyl-TTS in the management of radiotherapy induced acute pain and cancer pain treated with radiotherapy. MATERIALS AND METHODS: Our study was open labelled prospective phase IV multi-center study. the study population included patients with more 4 numeric rating scale(NRS) score pain although managed with other analgesics or more than 6 NRS score pain without analgesics. Patients divided into two groups; patients with radiotherapy induced pain (Group A) and patients with cancer pain treated with radiotherapy (Group B). All patients received 25 ug/hr of fentanyl transdermal patch. Primary end point was pain relief; second end points were change in patient quality of life, a degree of satisfaction for patients and clinician, side effects. RESULTS: Between March 2005 and June 2005, 312 patients from 26 participating institutes were registered, but 249 patients completed this study. Total number of patients in each group was 185 in Group A, 64 in Group B. Mean age was 60 years and male to female ratio was 76:24. Severe pain NRS score at 2 weeks after the application of fentanyl was decreased from 7.03 to 4.01, p=0.003. There was a significant improvement in insomnia, social functioning, and quality of life. A degree of satisfaction for patients and clinician was very high. The most common reasons of patients' satisfactions was good pain control. Ninety six patients reported side effect. Nausea was the most common side effect. There was no serious side effect. CONCLUSION: Fentanyl-TTS was effective in both relieving pain with good tolerability and improving the quality of life for patients with radiotherapy induced acute pain and cancer pain treated with radiotherapy. The satisfaction of the patients and doctors was good. There was no major side effect.
